Oxidative Medicine and Cellular Longevity
Volume 2019 (2019), Article ID 7058350, 18 pages
https://doi.org/10.1155/2019/7058350

Review Article

Stay Fit, Stay Young: Mitochondria in Movement: The Role of Exercise in the New Mitochondrial Paradigm

Jesus R. Huertas,¹ Rafael A. Casuso,¹ Pablo Hernansanz Agustín,² and Sara Cogliati1,2

¹Institute of Nutrition and Food Technology, Biomedical Research Centre, Department of Physiology, University of Granada, Granada, Spain
²Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain

Correspondence should be addressed to Sara Cogliati; sara.cogliati@cnic.es

Received 25 January 2019; Revised 23 April 2019; Accepted 8 May 2019; Published 19 June 2019

Guest Editor: Livia Hool

Copyright © 2019 Jesus R. Huertas et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract.

Skeletal muscles require the proper production and distribution of energy to sustain their work. To ensure this requirement is met, mitochondria form large networks within skeletal muscle cells, and during exercise, they can enhance their functions. In the present review, we discuss recent findings on exercise-induced mitochondrial adaptations. We emphasize the importance of mitochondrial biogenesis, morphological changes, and increases in respiratory supercomplex formation as mechanisms triggered by exercise that may increase the function of skeletal muscles. Finally, we highlight the possible effects of nutraceutical compounds on mitochondrial performance during exercise and outline the use of exercise as a therapeutic tool in noncommunicable disease prevention. The resulting picture shows that the modulation of mitochondrial activity by exercise is not only fundamental for physical performance but also a key point for whole-organism well-being.

1. Introduction

Commonly speaking, exercise is a physical activity that works the body at greater intensity than usual movements. To work at higher intensity, the body, particularly the skeletal muscles and the cardiovascular system, requires an extra supply of energy. Mitochondria are the main energy suppliers that coordinate AT production, reactive oxygen species (ROS) production, and calcium signaling, which are fundamental processes for sustaining body activity during exercise. Thus, exercise and mitochondria are in a close relationship and influence each other. This review is focused on this relationship, providing an overview of the most relevant works in the literature. Moreover, since diet can influence mitochondrial activity, we discuss how the use of some nutraceutical products can modulate physical performance. Lastly, we underline the use of exercise as a cost-effective primary intervention to prevent and delay metabolic syndrome and cardiovascular disease. Thus, the exercise-mitochondria interaction is not only an energetic matter but also an important aspect that must be understood to improve the use of exercise for both community members and athletes.

2. Mitochondria: The Hub of Energy Production

Mitochondria are defined as the energetic center of cells because they are the site of the oxidative phosphorylation (OXPHOS) system. The OXPHOS system is located in the mitochondrial cristae and is composed of the complexes of the electron transport chain (ETC) and the ATP synthase. The four complexes of the ETC are complex I (NADH-ubiquinone oxidoreductase), complex II (succinate-quinone oxidoreductase), complex III (ubiquinol-cytochrome bc₁ oxidoreductase), and complex IV (cytochrome c reductase). Using ubiquinone and cytochrome c, these complexes couple electron transport with proton pumping to generate a gradient that is used by ATP synthase to phosphorylate ADP and produce ATP. For decades, it was thought that the mitochondrial respiratory complexes were found as isolated entities [1]. However, it is currently widely accepted that respiratory complexes can be assembled into supramolecular entities called supercomplexes (SCs) [2, 3] whose structures have been described in detail, though not fully characterized, by several important and elegant studies involving cryo-EM [4–6]. SCs have been described in different organizations from yeast to plants and mammals [2, 7–10]. Accordingly, in the plasticity model, SCs and complexes can coexist and have dynamic interactions [7] that can be modulated by tissue-specific subunits [11] according to the energetic requirement of the cells [12, 13]. It has been demonstrated that SCs can (i) enhance the efficiency of electron flux by segmentation of the CoQ pool [14], (ii) prevent ROS formation by complex I and complex III as demonstrated by Lenaz and Genova [15] and (iii) improve the stability of the individual respiratory complexes [16–18]. However, many questions remain in the field, particularly if SC assembly is necessary for enhancing mitochondrial respiratory efficiency and what role SCs play in sustaining and determining metabolism. More evidence is required to definitively answer these questions and define the roles of SCs.

The discovery of the first bona fide SC assembly factor, supercomplex assembly factor 1 (SCAF1) [12], demonstrated that SCs are genetically regulated structures. SCAF1 is a small protein of 13 kDa that is homologous to the CIV subunit Cox7a2. SCAF1 brings together CIII and IV. Surprisingly, CD1 and SV129 mice have the wild-type protein, while C57BL/6J and Balb/cJ mice suffer a mutation that displaces a critical histidine residue in the matrix-exposed domain that is important for the interaction with CIV. As a result, liver mitochondria from C57BL/6J and Balb/cJ mice do not have III₂+IV and I+III₂+IV (either defined as the respirosome). This different organization of the respiratory chain determines higher respiration rates and ATP production in C57BL/6J and Balb/cJ mice when fueled with pyruvate/malate (NADH route) or succinate (FADH₂) that cannot be increased with the simultaneous fueling of both substrates as in CD1 and SV129 mitochondria. Our proposed model suggests that SCAF1, by defining three different populations of IV (the first linked to I and receiving the electron from the route of NADH, the second associated with III₂ and dedicated to the route of FADH₂, and a third that can receive the electrons from both routes), prevents saturation of electron channeling with one substrate, promoting the optimal use of energetic substrates, and suggests the existence of preferential pools of coenzyme Q (CoQ).

However, since the heart and muscle mitochondria from C57BL/6J mice retain a significant amount of respirosome [11], some authors doubt that SCAF1 is required for its formation [19, 20] and for the channeling of electrons through preferential pools of CoQ. From a structural point of view, using extensive proteomic analysis, we demonstrated that the respirosome from BL6 mice incorporates the COX7A2 subunit, which is specific to the monomeric status of complex IV, instead of SCAF1, suggesting that different respirosomes can exist in which CIII and IV undergo different interactions [11]. These results could be in agreement with the most recent cryo-EM structures of Letts et al.’s group, in which a loose and tight form of I+III₂+IV was described [4]. Regardless, the debate is still open, and a deep analysis of the structures, compositions, and functions of these SCs is urgently needed to understand whether these two structures are indeed different SCs with different functions and metabolic outcomes.

Another important element for the organization of the SCs of the ETC is crista morphology [21]. Cristae are specialized compartments of the mitochondrial inner membrane that are considered to be the platform on which SCs are clustered and assembled. Their remodeling is a tool for modulating mitochondrial metabolism and regulating the assembly and stability of SCs [21, 22]. It has been known that mitochondria continuously modulate their shape in an equilibrium between fusion and fission to maintain their function and eliminate damaged mitochondria during the so-called mitochondrial life cycle [23]. However, increasing evidence has demonstrated that adjusting morphology is a strategy to modulate mitochondrial bioenergetics and cope with the energetic demand of cells [24]. In the presence of excess nutrients, mitochondria divide to uncouple the electron transport chain and reduce ATP production [25], as occurs after treatment with uncouplers. On the other hand, mitochondria elongate in response to sustained deprivation of nutrients and escape from massive autophagy [26] that would ultimately be detrimental for the cell. In both situations, the molecular mechanisms, although not fully identified, involved the family of mitochondrial shaping proteins in which OPA1 processing and DRP1 recruitment control mitochondrial fission, while mitofusin expression and OPA1 cooperate for mitochondrial fusion [27].

Changes in mitochondrial morphology and remodeling of the SCs’ structure during exercise will be discussed in detail in the following sections.

3. The Energetic Demand of Exercise

Skeletal muscle contractile activity is directly dependent on the supply of adenosine triphosphate (ATP) to three ATPases: myosin, Na+-K+, and sarcoplasmic reticulum Ca2+ [28].

However, the amount of mammalian intramuscular ATP allows the maintenance of high-intensity exercise for only a few seconds. Therefore, from a bioenergetic point of view, exercise constitutes an energetic challenge within skeletal muscle cells. Skeletal muscle possesses a number of ATP synthetic pathways that permit high ATP turnover even during strenuous exercise. These pathways engage both anaerobic, substrate-level phosphorylation, and aerobic metabolism, which is highly dependent on the oxygen delivered by the cardiovascular system to the skeletal muscle [28] (Figure 1).

Figure 1: Energy system contribution during exercise. CK: Krebs cycle; I, III, IV: mitochondrial complexes; V: ATP synthase: FADH: reduced flavin adenine dinucleotide; NADH: reduced nicotinamide adenine dinucleotide; ATP: adenosine triphosphate; ADP: adenosine monophosphate.

During the first seconds of intense exercise, ATP is produced at the substrate level via creatine kinase (CK), an enzyme mainly present in the cytosol that catalyzes a reversible reaction in which phosphocreatine (PCr) converts adenosine diphosphate (ADP) to ATP, forming creatine (Cr) (Figure 2):

Figure 2: The creatine kinase/phosphocreatine system. Compartment-specific isoenzymes of creatine kinase (CK) are found in mitochondria (Mt-CK) and cytosol (c-CK). PCr: phosphocreatine, Cr: creatine, ATP: adenosine triphosphate, ADP: adenosine monophosphate.

As CK is high in cytosol, small increases in ADP trigger the degradation of creatine phosphate, leading to ATP production.

However, during high-intensity exercise, this system provides ~50% of the ATP during the first 6 s of exercise, while the most predominant substrate for the next 10 s is glycolysis [29]. These events are concomitant due to an increase in sarcomeric (Ca⁺) and inorganic phosphate (Pi), leading to the production of high levels of pyruvate, mainly due to glycogenolysis. These pathways are activated in the cytosol; however, pyruvate can either be metabolized in the cytosol and produce lactate [30] or enter into the mitochondria for oxidation (i.e., anaerobic or aerobic glycolysis, respectively). Indeed, glycolysis by-products activate the main mitochondrial enzyme responsible for carbohydrate oxidation, pyruvate dehydrogenase (PDH) [29]. If exercise intensity continues to increase, the glycolytic efflux also increases, and pyruvate production exceeds the oxidation rate of PDH, leading to lactate generation. Therefore, the degree of oxidative metabolism during exercise is inversely related to the intensity of exercise. For instance, sprint running events lasting <10 s, such as world-class 100 m running, can be sustained using mainly PCr hydrolysis. Events up to ~60 s, such as 400 m running or 100 m swimming, mainly use anaerobic glycolysis, while longer races mainly use aerobic metabolism.

Although anaerobic glycolysis starts as soon as muscle contraction starts, its contribution is mainly from 10-60 s of intense exercise [31]. This process requires the stored glycogen to produce lactic acid and ATP. Thus, the importance of adequate skeletal muscle glycogen levels before intense exercise is highlighted as follows:

Exercise beyond 60 s requires oxygen to oxidize glucose or fatty acids to carbon dioxide:

As oxygen is a key factor in the latter metabolic pathway, mitochondria play a predominant role during most exercise conditions. It should also be noted that even if 30 s sprints are repeated over time, after the third repetition, most of the ATP is provided by oxidative mechanisms [29]. Therefore, some of the mitochondrial adaptations related to sprint exercise (see below) can be attributed to the fact that a repeated effect compromises oxidative phosphorylation. Nevertheless, during prolonged submaximal exercise, the oxidative metabolism of carbohydrates and lipids almost fulfils all the cellular ATP needs, but the relative contribution of each substrate (i.e., fatty acids and glucose) is also a matter of exercise intensity. The maximal fat oxidation rates occur at intensities ~60% of VO₂max [32], but as intensity increases, the glycolytic flux increases due to decrements in plasma fatty acid (FA) delivery to contracting muscles and a decreased capacity for mitochondrial FA uptake and oxidation [33]. It should, however, be noted that PCr hydrolysis, glycolysis, and oxidative phosphorylation work simultaneously during exercise and that the relative contributions of these components vary in response to exercise intensity (Figure 3).

Figure 3: The energy systems that contribute to sport practice. The phosphagen system (ATP-CP) is used in explosive movements (Immediate energy). Anaerobically created energy overlaps with use of the ATP-CP system to provide energy for activities lasting up to around 3 minutes. Aerobic glycolysis provides energy for longer-distance events by breaking down fat and some carbohydrates.

4. The Role of Mitochondria in Exercise

Mitochondria are the organelles where oxidation meets phosphorylation to generate ATP for contracting muscles. In fact, since the early studies by John O. Holloszy [34], it has been clear that exercise elicits mitochondrial adaptations [35]. In addition, subsequent studies in rodents demonstrated that the increase in mitochondrial enzyme activity induced by exercise first observed by Holloszy (1967) was due to increases in mitochondrial size and number [36]. These pioneering studies suggested that the maximal oxygen uptake (VO₂max) and the whole-body aerobic capacity were also limited by skeletal muscle mitochondrial content and not only by cardiorespiratory factors, as previously thought. Accordingly, some studies have linked skeletal muscle mitochondrial content and ATP supply with skeletal muscle performance [37, 38]. This finding suggests that mitochondria may set the limit of maximum O₂ uptake by skeletal muscle. This assumption makes sense because mitochondria link oxygen delivery to ATP synthesis to meet the energetic needs of the skeletal muscle. Therefore, exercise training is a key factor that can enhance mitochondrial bioenergetics efficiency.

In fact, endurance exercise training can increase the mitochondrial content per gram of tissue as well as the mitochondrial composition (protein-to-lipid ratio), thereby improving aerobic metabolism [39]. In addition, exercise training can improve mitochondrial metabolism by increasing the ATP supply per O₂ molecule (P/O). In fact, oxidative phosphorylation is a highly malleable biochemical process [40], in which the ETC oxidizes NADH to pump H+ through the inner mitochondrial membrane. Then, the proton motive force is used by the F₁F₀-ATP synthase to produce phosphorylation. Another step that can be optimized within trained skeletal muscle mitochondria is H+ leakage through the inner mitochondrial membrane, thus bypassing phosphorylation. Overall, aerobic exercise training improves skeletal muscle O₂ uptake, which directly affects aerobic exercise performance, thereby increasing fatty acid (FA) oxidation and limiting lactate production at a given exercise intensity. This effect can occur due to a rise in skeletal muscle content and size but also due to improvements in the oxidative phosphorylation system.

It is important to highlight that two different pools of mitochondria exist within the skeletal muscle and the heart. The subsarcolemmal (SS) mitochondria are located close to the sarcolemma, while intermyofibrillar (IMF) mitochondria are located between myofibrils. Notably, SS mitochondria are often in close contact with the peripherally located mitochondria (i.e., functional) myonuclei. Therefore, it has been proposed that the main function of SS mitochondria is to energetically support nuclear and sarcolemmal functions [41]. However, IMF mitochondria show higher biochemical activity and ATP concentrations [42], possibly to efficiently provide ATP for myosin ATPase, thereby sustaining myofibril contraction. With regard to exercise training, a higher trainability of SS than IMF mitochondria has been observed. In fact, the volume density of SS mitochondria is ~0.1-0.2% in untrained subjects, which can increase up to ~3.4% in highly trained subjects [43]. However, the IMF volume density is ~4.5% in untrained subjects, while increases up to ~7.5% have been described [43].

Therefore, it can be inferred that in response to exercise, SS mitochondria increase their volume to a greater extent than do IMF mitochondria. However, the rationale for these divergent responses to exercise between mitochondrial subpopulations is unknown. A possible explanation matches the power-transmitting cables, which suggest that oxygen from capillaries is consumed by SS mitochondria and that the ions can then be pumped to IMF mitochondria [44]. Therefore, the power-transmitting cables can energetically interconnect oxygen-rich areas, such as those close to the sarcolemma, and deeper areas of the muscle fiber. This adaptation has not been directly observed in response to exercise. However, the enlargement of the mitochondrial reticulum reported in response to exercise [45–47] together with the stronger adaptations described within SS mitochondria suggests that trained skeletal muscle may be adapted towards improving the distribution of energy through skeletal muscle cells. Nevertheless, given that little on the SS and IMF response to exercise has been reported, in the present review, we will discuss the general response of the mitochondrial reticulum.

5. Exercise Influences Mitochondria, Which in Turn Influence Exercise

Within the mammalian skeletal muscle, mitochondria are mainly found forming large networks [48], which allows a rapid electrical interconnection between adjacent organelles [49]. This network highlights the plasticity of skeletal muscle mitochondria in response to cellular energetic challenges. Indeed, pioneering work by Palladin [50] showed that electrically stimulated skeletal muscle increased mitochondrial respiration. This work is also important because it introduced the concept of trainability with regards to mitochondrial function. In fact, in response to a single exercise session, there is a loss of homeostatic function that triggers a number of responses at the cellular (but also systemic) level to soften the next homeostatic challenge. For instance, if the homeostatic threat is triggered by endurance exercise (i.e., 60-90% VO₂max) where the maintenance of ATP production mainly relies on the aerobic pathways, then the response will operate to improve such pathways. This effect is in accordance with the fact that endurance trained subjects show higher skeletal muscle mitochondrial volume than do sedentary subjects [51, 52]. The increase in mitochondrial volume seems to be one of the most important effects that improves endurance performance [53]. Indeed, in the present section, we will review the initial signals leading to an acute mitochondrial response (i.e., acute effect) and the repeated bout effect leading to a more permanent mitochondria adaptation (i.e., chronic effect). It should also be noted that mitochondria are highly plastic organelles that in response to the energetic challenges of the cell undergo several remodeling changes, which include [27] de novo mitochondrial biogenesis, mitochondrial fusion, and fragmentation of dysfunctional organelles (fission) for their breakdown by the autophagosome (mitophagy). It is important to note that all of these processes are triggered by acute and/or chronic exercise [54]. All these changes are detailed in the following paragraphs and depicted in Figure 4.

Figure 4: Exercise-induced mitochondrial signaling and biogenesis in skeletal muscle. ATP: adenosine triphosphate; ADP: adenosine monophosphate; NAD+/NADH: oxidized/reduced nicotinamide adenine dinucleotide; HIF-1α: hypoxia-inducible factors; p38 MAEK: P38 MAPK mitogen-activated protein kinase; CaMK: Ca²⁺/calmodulin-dependent protein kinase: AKT: serine/threonine-specific protein kinase; CREB: cAMP response element-binding protein; ATF2: activating transcription factor 2; MEF2: myocyte enhancer factor-2; AMPK: AMP-activated protein kinase; PGC-1: PPARγ coactivator-1; PPARγ: peroxisome proliferator-activated receptor γ; ROS: reactive oxygen species; SIRT-1: sirtuin 1; TFAM: mitochondrial transcription factor A; TIM: translocase of the inner mitochondrial membrane; TOM; translocase of the outer mitochondrial membrane; AC: acetylated; P: phosphorylated.

5.1. Early Exercise-Induced Signaling towards Mitochondrial Remodeling

Exercise is known to impact a number of intracellular signaling pathways that orchestrate mitochondrial responses and/or adaptations in skeletal muscle. It should be noted that these molecular pathways overlap each other, making it difficult to isolate one signal from another. Indeed, muscle contractile activity concomitantly triggers at least 4 intracellular signaling pathways that control mitochondrial function [55]: (1) increases in intracellular calcium mainly derived from the sarcoplasmic reticulum, (2) increases in ATP turnover leading to a rise in intracellular AMP, (3) increases in the ratio of nicotinamide adenine dinucleotide (NAD+) to its reduced form NADH (NAD+/NADH), and (4) increases in reactive oxygen species (ROS) production.

Experiments in cultured cells revealed that contraction-inducing calcium release regulates mitochondrial function by activating both calcium-calmodulin kinase (CaMK) and protein kinase C [56–58]. In addition, the rise in ATP demands within contracting muscle increases adenosine monophosphate (AMP) levels, leading to the activation of AMP-activated protein kinase (AMPK) [59]. AMPK is known to be a key regulator of metabolism through the inhibition of anabolism, which minimizes ATP consumption and stimulates catabolism to stimulate ATP production [60]. In fact, AMPK activity has been associated with increased mitochondrial content [61, 62] and function [63]. In addition to these kinases, exercise-induced ROS production increases the activity of mitogen-activated protein kinase 38 (p38 MAPK) [64]. Finally, the rise in NAD+ production directly activates the deacetylase SIRT1 [65] in a mechanism that may be potentiated by AMPK by directly increasing the NAD+/NADH ratio [66]. It should be highlighted that all of these signals directly or indirectly activate peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1α) through phosphorylation, deacetylation, and/or regulation of its expression [55, 64, 67–69]. PGC-1α is a transcription factor that belongs to the peroxisome-activator receptor (PPAR) family. PGC-1α, together with other family members, such as PGC-related coactivator (PRC) and PGC-1β, regulates the expression of nuclear genes encoding mitochondrial proteins, thereby regulating mitochondrial content and function [70]. PGC-1α has been the best-studied family of nuclear receptors and accordingly is often referred to as the “master regulator” of mitochondrial biogenesis [55, 71, 72].

5.2. Mitochondrial Biogenesis

The definition of mitochondrial biogenesis is sometimes too general. In the present review, we will consider mitochondrial biogenesis as recently defined by Perry and Hawley [73]: “an expansion of total muscle mitochondrial volume.” This process requires a complex coordination of the transcription of the nuclear and the mitochondrial genome to assemble functional multisubunit respiratory chain proteins [52].

Early studies by John O. Holloszy [34] reported an association between mitochondrial content and exercise. More than thirty years later, the discovery of PGC-1α as a key controller of mitochondrial biogenesis shed more light on the molecular mechanisms triggered by exercise to increase mitochondrial content. As noted above, the activity of PGC-1α is coordinated by calcium, AMP, and ROS-related kinases, and all of these factors are highly sensitive to exercise-induced stress [74, 75]. These kinases regulate PGC-1α activity through phosphorylation. In addition, a single bout of exercise also increases PGC-1α activity through deacetylation by the NAD+-dependent deacetylase sirtuin 1 (SIRT1) [76]. However, the regulation of PGC-1α is not induced only at the posttranslational level. Indeed, it was observed that an acute bout of exercise increased the expression of PGC-1α [77–80]. Exercise-induced PGC-1α transcription is also controlled by CaMK and p38 MAPK, which phosphorylate the transcription factors myocyte enhancer factor 2 (MEF2) and activating transcription factor 2 (ATF2), leading to their translocation to the nucleus [81, 82]. Moreover, exercise induces PGC-1α translocation to the nucleus to both orchestrate mitochondrial biogenesis [83, 84] and self-regulate its own expression [85].

During the last decade, another transcription factor, the tumor suppressor protein p53, has also been identified as a powerful regulator of skeletal muscle mitochondrial content, function, and exercise capacity [86]. Research has found that p53 can be phosphorylated by p38 MAPK and AMPK [86–88]. Moreover, a single exercise session is known to deacetylate p53 by SIRT, which may help p53 to translocate to the nucleus [89]. Once in the nucleus, p53 regulates several nuclear-encoded mitochondrial proteins [90, 91]. Importantly, p53 can also be found inside the mitochondria in response to acute exercise, where it can affect mtDNA transcription [92]. Indeed, inside the mitochondria, p53 can form a complex with TFAM as well as with the mtDNA D-loop region, which controls the mitochondrial expression of some mitochondrial subunits. Therefore, p53 seems to be a transcription factor that can integrate the expression of both the nuclear and mitochondrial genomes in response to exercise. Mitochondrial biogenesis is often studied by using both biochemical and microscopy techniques. Exercise studies mainly use the activity, as well as the protein content, of citrate synthase (CS), succinate dehydrogenase (SDH), and cytochrome c oxidase (COX) as markers of mitochondrial biogenesis [55].

In addition, transmission electron microscopy (TEM) can be used to measure mitochondrial volume density (MitoVD) [45]. Moreover, mitochondrial respiratory function can be assessed from isolated mitochondria as changes in the mitochondrial ATP production rate and mass-specific mitochondrial respiration [93]. However, it has been observed in both rodents [94] and humans [93] that improvements in mitochondrial respiratory capacity can take place independently of changes in mitochondrial content. In an elegant study, healthy subjects were allocated for 4 weeks into 3 exercise groups: moderate continuous intensity training (MCIT), high-intensity interval training (HIIT), and sprint interval training (SIT) [95]. The results suggest that only SIT increases mitochondrial respiration, while the other groups showed no effect despite much higher training volumes. Another recent study showed that 6 weeks of MCIT showed an increase in MitoVD without affecting mitochondrial respiration [45].

Therefore, it is likely that exercise intensity is a key aspect in regulating mitochondrial function. Interval exercise is commonly subdivided into HIIT and SIT. HIIT is often carried out at intensities >80% of the maximal heart rate and usually involves bouts of 1.5-16 min interspersed with 2-3 min of rest [96, 97]; SIT is usually performed as all-out exercise bouts lasting 6 to 90 s interspersed with periods of rest of 1 to >5 times the duration of the exercise [98]. MCIT is performed in a continuous manner and at lower intensities than internal exercise is. In recent years, a number of studies have investigated the mitochondrial adaptations induced by different exercise regimens. A recent paper by Perry et al. [99] analyzed PGC-1α mRNA expression during 7 HIIT sessions carried out over 2 weeks. Their data may suggest that intense exercise induces stronger and more rapid mitochondrial adaptation than MCIT does. However, it has been reported that SIT [100] and MCIT [74] increase CS activity to a similar extent 24 h following an acute exercise bout. Instead, exercise intensity may be an efficient approach to elicit mitochondrial adaptations. Indeed, two studies are aimed at comparing the mitochondrial adaptations elicited by two weeks of either SIT or MCIT [101, 102]. They found similar increases in both CS and COX activities even though MCIT comprised 4.5 h of weekly training, while SIT comprised only 10 min of effective weekly training. However, it remains unclear how extremely low-volume SIT induces such an efficient effect. It has been suggested that SIT-induced ROS production might be a possibility [103]. Accordingly, it has been observed that SIT-induced ROS production over two weeks of training induces the fragmentation of the ryanodine receptor (RyR), leading to postexercise Ca⁺ accumulation [104]. This finding is in accordance with the observation that calcium-related signaling seems to be important in response to acute SIT exercise [105]. In addition, a more recent study highlighted that β-adrenergic stimulation, muscle lactate accumulation, and skeletal muscle pH reduction seem to be important to elicit the SIT-related molecular cascade leading to mitochondrial biogenesis [75]. Therefore, the above studies suggest that mitochondria respond rapidly to exercise stimuli and that intense exercise of short duration may be an efficient strategy to achieve mitochondrial adaptations.

In addition, it seems plausible that different exercise intensities elicit divergent mitochondrial adaptations. In a recent study, subjects performed six sessions of HIIT with one leg, while the other leg performed MCIT, with similar volumes between legs [106]. In these subjects, HIIT was the only intervention that increased CS maximal activity and OXPHOS capacity. It should, however, be noted that neither HIIT nor MCIT increased mitochondrial respiration as assessed by OXPHOS capacity normalized to CS maximal activity [103]. Indeed, another study compared the effects of 4 weeks of MCIT-, HIIT-, and SIT-based training in healthy subjects [95]. The authors found that although all the interventions increased the expression of the transcription factors p53 and PGC-1α, only SIT increased mass-specific mitochondrial respiration. It can be argued that the higher the intensity, the more type 2 fibers are recruited [35]; thus, the increased mitochondrial respiration could be due to phenotype changes. However, the best controlled study (regarding its within-subject design) showed no differences between MCIT and HIIT in COX activity within type 2 skeletal muscle fibers [103]. In contrast, in a recent review, the authors provide valuable relationships between mitochondrial adaptations and exercise intensity by plotting the data of available human studies [93]. Among the truly important observations, it should be highlighted that the authors conclude that high-volume low-intensity (i.e., MCIT) training is important to increase mitochondrial content. However, exercise intensity seems to be important in increasing mass-specific mitochondrial respiration [93]. Therefore, divergent exercise stimuli may trigger different molecular pathways leading to different mitochondrial properties and possibly dynamics.

5.3. Mitochondrial Dynamics

Mitochondria can undergo dynamic morphological changes that involve crista remodeling, fusion, and fission, which collectively regulate cellular function [27]. Indeed, mitochondria not only regulate their shape to adapt to the energetic needs of the cells but also maintain an internal quality control in which damaged mitochondria are eliminated by the autophagosome. During exercise, the higher energetic demands acutely induce mitochondrial morphological changes, which may indeed regulate long-term mitochondrial bioenergetics [54] and help to maintain mitochondrial functions (Figure 5).

Figure 5: Mitochondrial dynamics is affected by/during exercise. PGC-1: PPARγ coactivator-1; ROS: reactive oxygen species; FIS1: mitochondrial fission 1 protein; Drp1: dynamin-related protein 1; OPA1: mitochondrial dynamin like GTPase; MFN1/2: mitofusin 1 and 2 protein.

In rodents, it was recently shown that acute running exercise increases dynamin-related protein 1- (DRP1-) induced mitochondrial fission and mitophagy efflux [107]. In addition, using a combination of transmission electron microscopy and molecular biology, Lavorato et al. [108] reported that both exercise running to exhaustion and electrical stimulation result in mitochondrial fission in a DRP1-dependent manner. Therefore, in rodents, acute exercise seems to activate DRP1 pathways, leading to mitochondrial fission and increased mitophagy efflux; however, the mechanisms are yet to be elucidated. It was initially thought that exercise-induced AMPK phosphorylation at Thr172 was the upstream mechanism triggering mitochondrial fragmentation and mitophagy [54]. However, more recent studies suggest that AMPK is responsible for exercise-induced mitophagy but not DRP1-related fission [107]. In this regard, mitochondrial fission factor (MFF) is a mitochondrial outer membrane that involves the recruitment of DRP1 from the cytosol to the mitochondrial surface to catalyze the fission reaction. Notably, it has been demonstrated that mitochondrial stress induced MFF phosphorylation by AMPK, thus increasing mitochondrial fission [109]. Thus, AMPK seems to couple fission and mitophagy in response to cellular stress. However, whether exercise-induced AMPK activation results in MFF-related fission has yet to be determined. Interestingly, during atrophy induced by denervation or fasting, there is massive mitochondrial fission, leading to an exacerbated autophagy that leads to muscle wasting. This event can be prevented by expressing a Drp1-negative mutant and knocking down AMPK [110], suggesting that the Drp1-AMPK axis is involved not only in exercise-induced autophagy but also in muscle atrophy-induced autophagy. While the first seems to have a role in quality control, the latter is an extreme event resulting in deleterious effects. Whether it is only a quantitative matter or whether the activation of these molecular mechanisms requires different interactors is still to be discovered. A very recent paper reported that Drp1-/- mice have altered muscle adaptation upon exercise that results in reduced running performance. This finding definitively demonstrates that fission and Drp1 in particular are key elements for muscle activity and physiology [111].

On the other hand, mitochondrial fusion and elongation of the mitochondrial network have been proposed to occur in response to cellular energetic reductions [26, 112] and are regulated by three GTPases: mitofusin 1 (MFN1), mitofusin 2 (MFN2), and optic atrophy 1 (OPA1). Once two mitochondria come into close contact, MFN1 and MFN2 change their molecular conformation to permit mitochondrial outer membrane fusion [113]. Inner membrane mitochondrial fusion is known to be regulated by OPA1 [27]. In addition, MFN expression seems to be regulated by PGC-1s and by the estrogen-related receptor (ERR) [114, 115]. In fact, exercise-induced PGC-1α translocation to the skeletal muscle nucleus is known to induce MFN1 and MFN2 expression in human skeletal muscle in an ERR-dependent manner [116]. However, direct evidence of exercise-induced mitochondrial fusion is lacking. Picard et al. [117] showed that acute voluntary running in mice increases electrodense mitochondrial contact sites, but no effect on MFN2 and OPA1 was observed. In addition, a recent study using skeletal muscle PGC-1α KO mice showed that exercise-induced mitochondrial network elongation is dependent upon PGC-1α suppression of mitochondrial fission 1 (FIS1) rather than MFNs or OPA1 [118]. Therefore, within exercised skeletal muscle, PGC-1α may promote a profusion environment by suppressing fission activity.

In humans, it has been observed that long-term exercise induces an enlargement of the mitochondrial network [45, 46], which may help to electrically interconnect the sarcolemma and the core of the muscle cell, thereby linking oxygen rich areas to those areas with limited oxygen availability [44, 49]. As mitochondrial fusion occurs in parallel with skeletal muscle energetic reduction [112], it seems plausible that acute exercise may also induce rapid mitochondrial fusion events. However, studies aiming to study the effects of either acute or long-term responses to exercise on mitochondrial fusion are lacking. Cartoni et al. [116] reported that well-trained cyclists performing strenuous continuous cycling showed increases in MFN mRNA levels but not protein levels in the 24 h following the exercise.

More recently, it has been reported that both SIT and MCIT lead to rapid MFN2 mRNA expression [84]. In addition, Fiorenza et al. [75] showed that both MCIT and SIT but not extremely low-volume SIT increased MFN2 mRNA levels 3 h postexercise. Regarding the cumulative effect of several weeks of training, it has been reported that in previously untrained subjects, MFN2 protein content increases following 6 weeks of MCIT [45]. In another study, moderately trained individuals were allocated to SIT, HIT, and MCIT for four weeks [95]. The results show that all of the exercise interventions increased skeletal muscle MFN2 protein content. In addition, in an elegant study, Perry et al. [99] studied time-course responses of skeletal muscle signaling in moderately trained subjects during two weeks of HIIT. They found that MFN1 but not MFN2 protein content increases at the end of the training period.

These results show the complexity of the mitochondrial fusion machinery. In addition, discrepancies between studies could be due to differences in the subject’s characteristics and/or methodological issues. Interestingly, OPA1, the master of mitochondrial cristae, has been found to be downregulated in biopsies of older sedentary humans but not older sportsmen, suggesting that exercise counteracts aging-related sarcopenia [119]. To understand the molecular mechanism, the authors specifically depleted Opa1 in the muscle, and they demonstrated that the lack of OPA1 induces mitochondrial dysfunction, leading not only to an impairment of muscle activity but also to precocious senescence and degeneration of multiple organs caused by the activation of ER stress and the unfolded protein response (UPR) mediated by an increase in serum levels of FGF21. This paper [119] not only identified OPA1 as a sensor of exercise but also demonstrated for the first time how the modification of mitochondrial activity through morphology can have a systemic effect, underlining the importance of a holistic approach to study mitochondria.

Moreover, the molecular mechanisms underlying mitochondrial fusion in response to exercise remain to be elucidated, and further studies combining molecular signaling and microscopy technology can help to unravel mitochondrial dynamics in response to exercise.

In addition, other factors can also affect mitochondrial dynamics in response to exercise. For instance, it has been reported that as early as the third HIT session, both FIS1 and DRP1 protein contents increase in moderately trained subjects [99]. However, this report is in contrast with recent results showing a stronger profusion rather than profission environment within the skeletal muscle of aged subjects subjected to six weeks of HIIT [120]. This discrepancy could occur because aged skeletal muscles show a blunted mitophagy capacity, leading to the accumulation of damaged mitochondria [121]. In addition, the phenotype of the skeletal muscle studied may also impact the mitochondrial responses to exercise. In fact, it has been reported that two weeks of SIT engaging both the arms and legs or the legs but not the arms increased mitochondrial respiration [122]. This effect likely occurs because the arms and legs show different phenotypes [123, 124]. Therefore, mitochondrial dynamics in response to exercise seems to be an interesting area for future research. Future studies should determine the molecular mechanisms underlying mitochondrial fission and fusion in response to exercise in health and disease. Moreover, skeletal muscle phenotypic differences regarding mitochondrial dynamics in response to exercise may help to shed light on the effects of exercise on mitochondrial and cellular metabolism.

5.4. Mitochondrial Function and SCs

Regular exercise increases mitochondrial crista density, thereby improving cellular function and ultimately whole-body VO₂max [124]. Since cristae are the privileged site of the OXPHOS system [125] whose shape is fundamental for the assembly and stability of SCs [21], we can hypothesize that increasing crista density could increase SC formation. Recent studies have observed that endurance exercise induces mitochondrial complex assembly into SCs. In rats, ten weeks of treadmill running increases SC assembly, thereby improving mitochondrial oxidative status [126]. In a very elegant study, Amati’s group [127] demonstrated how 4 months of moderate-intense aerobic exercise increases muscle respiration in older sedentary adults. From the molecular point of view, they found that all respiratory complexes, but particularly CI, were upregulated and redistributed to SCs. The overall result is that SC formation is enhanced upon exercise and correlates with better mitochondrial respiration. This work reveals for the first time in humans how SC formation could be an adaptive response to increase mitochondrial respiration and satisfy higher energetic demand [127]. Moreover, it has been proposed that SIT but not MCIT increases mitochondrial respiration without increasing mitochondrial volume. This observation suggests that exercise intensity might be an important determinant in SC assembly.

Although SIT protocols are known to increase circulating lactate levels over 13 mmol/L [128, 129], the repeated sprint bout effect on oxidative phosphorylation described by Parolin et al. [29] may suggest an impact on mitochondrial SC assembly. Related to the advantages of SC formation already discussed in a previous section (Mitochondria: The Hub of Energy Production), the real advantage of having a higher SC/complex ratio is still under investigation, but it is now clear that situations involving impaired mitochondrial metabolism are correlated with less SC formation, as observed during aging [130], heart failure [131], and diabetes [132]. An additional advantage of SCs could be enhancing the enzymatic activity of the complexes, thus improving overall mitochondrial respiration. An early study measured CI and CIV activity from I+III₂ and I+III₂+IV isolated from bovine heart by Blue Native PAGE in-gel activity assay and by spectrophotometric activity after electroelution assay of the SC structures [133]. The results indicate more activity in the supercomplex-assembled CI and CIV. Later, different works confirmed this observation, especially in nervous system cells from animal models of Parkinson’s disease [134–136], and Amati’s work confirmed this finding in muscle [127]. However, even though these results seem to support this hypothesis, we must consider important technical details. Indeed, all of these results have been obtained either by Blue Native in-gel activity assay or spectrophotometric activity assay, which both have technical limitations. The former is a nonlinear nonquantitative assay, while the latter measures the total amounts of complexes and cannot discriminate the specific activity of assembled vs. not assembled complexes. Considering these aspects, we believe that the in vitro results are valid approximations but definitive experimental confirmation in vivo is still needed. Another fundamental question, which is still open, is which molecular mechanisms trigger exercise-induced SCs assembly.

It has been reported that the lipid composition of the inner mitochondrial membrane is important for SC stabilization3, but it has never been addressed whether lipid composition may change upon exercise. As explained previously, OPA1 is a sensor of exercise that is downregulated in old sedentary individuals [119]. Moreover, considering its importance for SC maintenance [21], we could speculate that increasing OPA1 content might be a molecular mechanism to increase SC formation upon exercise. Another critical element for the assembly of SCs is SCAF1 [12], which could be a molecular target of exercise to increase SC formation, but there is still no investigation in this direction. Those elements could be all targets of exercise-dependent SC formation, but further investigation is needed to understand how exercise impacts the assembly of SCs and their role in adaptive processes upon increasing energy demand.

6. Use of Mitochondrial Active Nutraceuticals to Improve Exercise

The present review highlights the wide range of adaptations that exercise training can elicit within skeletal muscle mitochondria. In addition, several studies have attempted to stimulate such effects by stimulating particular pathways using so-called exercise-mimetic compounds. In fact, Narkar et al. [137] proposed that pharmacological activation of AMPK activity in mice is enough to change the skeletal muscle phenotype towards a more oxidative phenotype. This possibility attracted the attention of exercise physiologists aiming at discovering new nutritional supplements to improve skeletal muscle performance and health.

Polyphenols are naturally occurring compounds with similar structures (several hydroxyl groups on aromatic rings) and are mainly found in fruits and vegetables. Polyphenols are known to regulate free radical scavenging, cellular signaling and transduction, gene expression, and cellular communication [138]. Two of the best-studied polyphenols are resveratrol, which is found in red wine, and quercetin, which is mainly found in apples and onions [139]. Both quercetin and resveratrol have been extensively studied by exercise physiologists, as they are known to promote mitochondrial biogenesis through PGC-1α signaling by targeting SIRT1 [140–143]. Accordingly, mice supplemented with either resveratrol or quercetin are known to increase their endurance running performance [142, 144]. Therefore, polyphenol supplementation may change the skeletal muscle phenotype and thereby improve overall physical fitness.

However, the results of human studies aiming at finding an ergogenic or healthy effect of polyphenols are contradictory. For instance, it has been reported that 30 days of resveratrol supplementation in obese subjects improves cardiovascular function and skeletal muscle metabolism [145]. However, in healthy postmenopausal women, there were no effects on cardiovascular outcomes, lipid metabolism, or glucose metabolism after 12 weeks of resveratrol supplementation [146]. Moreover, Glieman et al. [147] showed that resveratrol supplementation during exercise blunted the cardiovascular adaptations induced by exercise in older subjects. Notably, young subjects also show a blunted effect of resveratrol on the skeletal muscle adaptations induced by exercise [148]. Therefore, the health-related effects of resveratrol could be more evident in diseased than in healthy subjects, but there is also a negative interaction induced by resveratrol on exercise adaptations.

In agreement with this notion, quercetin is known to increase skeletal muscle SIRT1 mRNA levels in sedentary but not trained animals [143]. However, human studies also show contradictory data. It has been reported that supplementation with 1000 mg/d quercetin for 2 weeks increases intense cycling performance in sedentary subjects [149]. Notably, no effect of quercetin on ventilation, heart rate, or oxygen consumption was observed during 60 min of low-intensity steady-state cycling. In addition, MacRae and Mefferd [150] supplemented a cocktail of antioxidants with or without 300 mg of quercetin for 6 weeks in well-trained subjects. They found that those consuming quercetin increased exercise performance during a 30 km cycling time-trial. It should, however, be noted that all the cocktails contained 45 mg of caffeine, which could, at least, interfere with the observed results. In addition, Davis et al. [151] observed increases in VO₂max and ride time to exhaustion in untrained subjects following 7 days of consumption of 1000 mg/d quercetin. However, a meta-analysis classified the effects of quercetin on exercise performance as unlikely to translate into a real ergogenic effect [152]. In fact, Cureton et al. [153] designed a study in which several endurance and time-trial tests were analyzed following at least 7 days of supplementation with 1000 mg/kg quercetin. They found no ergogenic effect of quercetin; moreover, they found that skeletal muscle PCr recovery following 1 min of isometric contraction was unaffected by quercetin. In addition, well-trained subjects consumed chewing gum containing 1000 mg of quercetin and other antioxidants, while subjects in the control group consumed the same chewing gum without quercetin [149]. The subjects consumed these chewing gums for 14 days, during 3 days of intensified training period and for an additional 7-day period. The investigators found that quercetin improved the immunological response to the intensified training period but failed to detect changes in exercise performance and skeletal muscle mitochondrial biogenesis markers. Collectively, these findings suggest that in contrast to mouse studies, quercetin does not improve mitochondrial function in either sedentary or trained humans. In addition, any performance-related effect, which is more likely in sedentary subjects, may be due to an enhanced immunological response to exercise.

It is noteworthy that in either mice [143] or humans [147, 148], polyphenol supplementation seems to interfere with skeletal muscle adaptations to exercise. This harmful effect has not been studied in detail; however, the antioxidant properties of polyphenols may be the underlying mechanism. Indeed, an acute bout of exercise induces ROS production, and this ROS release is attenuated as the skeletal muscle adapts to exercise [154]. This observation suggests that exercise training induces so-called oxidative eustress, which is important for health because it maintains a balance between oxidants and antioxidants [155]. Accordingly, exercise-induced cellular adaptations are triggered by the signals transduced by the ROS produced at the mitochondrial and extramitochondrial levels [156, 157]. Accordingly, vitamin C and E supplementation during exercise impedes exercise-induced skeletal muscle adaptations in both humans and rats [158, 159]. It will therefore be of great value to identify whether different doses of polyphenols combined with exercise may target key mitochondrial pathways without affecting the redox balance elicited by exercise.

In addition, much attention has been paid to dietary nitrate (NO₃⁻) supplementation, as it has been linked to improvements in human exercise performance in a wide range of physical activities [160]. Among these effects, it is important to highlight that nitrate supplementation can reduce the O₂ cost of submaximal exercise. In fact, three to six days of nitrate supplementation enhances the mitochondrial coupling efficiency, thereby improving skeletal muscle P/O [161, 162]. However, more research is needed in this area because similar to the other supplements discussed above, the ergogenic potential of nitrate is blunted when combined with high-intensity exercise [163].

Finally, we would like to consider the gut microbiota, as it shares the property of nutrient metabolism with mitochondria [164]. In addition, it has been observed that the host’s fitness is related to gut immune function and microbiota function [165, 166]. Moreover, a bidirectional cross-talk between the gut microbiota and mitochondria has been proposed. In fact, this symbiotic-like relationship between the gut microbiota and mitochondria seems to be favored by exercise training [167]. Thus, the regulation of the mitochondria-gut axis in response to exercise will be a fertile area of research for years to come.

7. Therapeutic Use of Exercise

Exercise evokes a multisystem response that leads to health outcomes. In fact, exercise can be a useful tool for the treatment of a number of metabolic diseases [168, 169]. Exercise can revert the deleterious effects of disuse and aging [170] and has positive effects on type 2 diabetes and cardiovascular disease [171]. Indeed, it is currently widely accepted that exercise is medicine. However, this concept requires elucidation of the limit between physiological exercise and deleterious exercise to find a balance in the personalization of exercise [172]. The World Health Organization (WHO) and American Heart Association (AHA) recommend 150 minutes of moderate intensity physical activity or 75 minutes of vigorous physical activity weekly. The time intervals should be at least 10 minutes or more per session. However, these recommendations are currently under review, as it is unclear which exercise doses (i.e., time × intensity) are better to maximize the health-related effects of exercise. For instance, it has been recently reported that cardiorespiratory fitness is associated with reduced long-term mortality, and no upper limit of this benefit was observed [173]. This finding is in line with recent advice to perform three to five times the WHO physical activity recommendations to achieve maximal benefits [168].

In addition to the exercise dose, it is also important to highlight that the time of the day at which exercise is performed may also limit health benefits in subjects suffering from type 2 diabetes [174] and hypertension [175]. Therefore, future research must characterize the best exercise doses and regimens for both diseased and healthy populations. In addition, the implications of circadian rhythms for exercise-induced health benefits will also be an important field of research in upcoming years. However, it is clear that regular moderate intensity exercise is an easy and cost-free intervention to improve overall health.

Regarding the main topic of the present review, it should be noted that mitochondrial dysfunction is associated with aging, type 2 diabetes, and cardiovascular disease [176–178]. Although it is currently unclear whether mitochondrial dysfunction is a cause or a consequence of the disease, recent studies in rodents suggest that mitochondrial dysfunction triggers muscle atrophy in response to metabolic disease [179]. Therefore, exercise may induce, at least in part, its health benefits by improving mitochondrial function. In addition, reduced respiratory SC assembly has been observed in type 2 diabetic subjects [132] as well as in the aged heart [130] and the brain cortex of aged rats [180]. In addition, mitochondrial crista disruption is an important process that leads to heart failure [181]. These observations highlight the importance of maintaining mitochondrial function in general and the mitochondrial SCs in particular to prevent some metabolic diseases. Studies on how different types and doses of exercise affect SC organization in these diseases may help to shed light on the key molecular pathways involved in these metabolic diseases.

8. Future Perspectives

The effects of different exercise regimens on mitochondrial function need to be further studied. Of particular relevance seems to be the effect of exercise on mitochondrial fusion and fission in aged and diseased populations. In addition, whether exercise can improve mitochondrial P/O and skeletal muscle contraction efficiency due to mitochondrial SCs assembly is another important topic in the field.

Conflicts of Interest

The authors declare that there is no conflict of interest regarding the publication of this paper.

Authors’ Contributions

Jesus R. Huertas and Rafael Casuso equally contributed to this work.

Acknowledgments

We thank Prof. Giorgio Lenaz for inspiring the title of this review. The CNIC is supported by the Instituto de Salud Carlos III (ISCIII), the Ministerio de Ciencia, Innovación y Universidades (MCNU), and the Pro CNIC Foundation and is a Severo Ochoa Center of Excellence (SEV-2015-0505).

References

C. R. Hackenbrock, B. Chazotte, and S. S. Gupte, “The random collision model and a critical assessment of diffusion and collision in mitochondrial electron transport,” Journal of Bioenergetics and Biomembranes, vol. 18, no. 5, pp. 331–368, 1986.

H. Schägger and K. Pfeiffer, “Supercomplexes in the respiratory chains of yeast and mammalian mitochondria,” EMBO Journal, vol. 19, no. 8, pp. 1777–1783, 2000.

J. A. Enríquez, “Supramolecular organization of respiratory complexes,” Annual Review of Physiology, vol. 78, no. 1, pp. 533–561, 2016.

J. A. Letts, K. Fiedorczuk, and L. A. Sazanov, “The architecture of respiratory supercomplexes,” Nature, vol. 537, no. 7622, pp. 644–648, 2016.

M. Wu, J. Gu, R. Guo, Y. Huang, and M. Yang, “Structure of Mammalian Respiratory Supercomplex I 1 III 2 IV 1,” Cell, vol. 167, no. 6, pp. 1598–1609.e10, 2016.

J. Gu, M. Wu, R. Guo et al., “The architecture of the mammalian respirasome,” Nature, vol. 537, no. 7622, pp. 639–643, 2016.

R. Acín-Pérez, P. Fernández-Silva, M. L. Peleato, A. Pérez-Martos, and J. A. Enriquez, “Respiratory active mitochondrial supercomplexes,” Molecular Cell, vol. 32, no. 4, pp. 529–539, 2008.

H. Eubel, L. Jansch, and H. Braun, “New insights into the respiratory chain of plant mitochondria. Supercomplexes and a Unique Composition of Complex II,” Plant Physiology, vol. 133, no. 1, pp. 274–286, 2003.

F. Krause, N. H. Reifschneider, D. Vocke, H. Seelert, S. Rexroth, and N. A. Dencher, “‘Respirasome’-like supercomplexes in green leaf mitochondria of spinach,” Journal of Biological Chemistry, vol. 279, no. 46, pp. 48369–48375, 2004.

I. Marques, N. A. Dencher, A. Videira, and F. Krause, “Supramolecular organization of the respiratory chain in Neurospora crassa mitochondria,” Eukaryotic Cell, vol. 6, no. 12, pp. 2391–2405, 2007.

S. Cogliati, E. Calvo, M. Loureiro et al., “Mechanism of super-assembly of respiratory complexes III and IV,” Nature, vol. 539, no. 7630, pp. 579–582, 2016.

E. Lapuente-Brun, R. Moreno-Loshuertos, R. Acin-Perez et al., “Supercomplex assembly determines electron flux in the mitochondrial electron transport chain,” Science, vol. 340, no. 6140, pp. 1567–1570, 2013.

A. Guarás, E. Perales-Clemente, E. Calvo et al., “The CoQH2/CoQ ratio serves as a sensor of respiratory chain efficiency,” Cell Reports, vol. 15, no. 1, pp. 197–209, 2016.

G. Lenaz and M. L. Genova, “Kinetics of integrated electron transfer in the mitochondrial respiratory chain: random collisions vs. solid state electron channeling,” American Journal of Physiology-Cell Physiology, vol. 292, no. 4, pp. C1221–C1239, 2007.

G. Lenaz, G. Tioli, A. I. Falasca, and M. L. Genova, “Complex I function in mitochondrial supercomplexes,” Biochimica et Biophysica Acta (BBA) - Bioenergetics, vol. 1857, no. 7, pp. 991–1000, 2016.

R. Acı́n-Pérez, Marı́a P. Bayona-Bafaluy, P. Fernández-Silva et al., “Respiratory complex III is required to maintain complex I in mammalian mitochondria,” Molecular Cell, vol. 13, no. 6, pp. 805–815, 2004.

F. Diaz, H. Fukui, S. Garcia, and C. T. Moraes, “Cytochrome c oxidase is required for the assembly/stability of respiratory complex I in mouse fibroblasts,” Molecular and Cellular Biology, vol. 26, no. 13, pp. 4872–4881, 2006.

U. D. Vempati, X. Han, and C. T. Moraes, “Lack of Cytochromecin Mouse Fibroblasts Disrupts Assembly/Stability of Respiratory Complexes I and IV,” Journal of Biological Chemistry, vol. 284, no. 7, pp. 4383–4391, 2009.

R. Pérez-Pérez, T. Lobo-Jarne, D. Milenkovic et al., “COX7A2L Is a Mitochondrial complex III binding protein that stabilizes the III2+IV supercomplex without affecting respirasome formation,” Cell Reports, vol. 16, no. 9, pp. 2387–2398, 2016.

A. Mourier, S. Matic, B. Ruzzenente, N. G. Larsson, and D. Milenkovic, “The respiratory chain supercomplex organization is independent of COX7A2L isoforms,” Cell Metabolism, vol. 20, no. 6, pp. 1069–1075, 2014.

S. Cogliati, C. Frezza, M. E. Soriano et al., “Mitochondrial cristae shape determines respiratory chain supercomplexes assembly and respiratory efficiency,” Cell, vol. 155, no. 1, pp. 160–171, 2013.

S. Cogliati, J. A. Enriquez, and L. Scorrano, “Mitochondrial cristae: where beauty meets functionality,” Trends in Biochemical Sciences, vol. 41, no. 3, pp. 261–273, 2016.

G. Twig, B. Hyde, and O. S. Shirihai, “Mitochondrial fusion, fission and autophagy as a quality control axis: the bioenergetic view,” Biochimica et Biophysica Acta (BBA) - Bioenergetics, vol. 1777, no. 9, pp. 1092–1097, 2008.

M. Liesa and O. S. Shirihai, “Mitochondrial dynamics in the regulation of nutrient utilization and energy expenditure,” Cell Metabolism, vol. 17, no. 4, pp. 491–506, 2013.

A. J. A. Molina, J. D. Wikstrom, L. Stiles et al., “Mitochondrial networking protects beta-cells from nutrient-induced apoptosis,” Diabetes, vol. 58, no. 10, pp. 2303–2315, 2009.

L. C. Gomes, G. Di Benedetto, and L. Scorrano, “During autophagy mitochondria elongate, are spared from degradation and sustain cell viability,” Nature Cell Biology, vol. 13, no. 5, pp. 589–598, 2011.

L. Pernas and L. Scorrano, “Mito-morphosis: mitochondrial fusion, fission, and cristae remodeling as key mediators of cellular function,” Annu. Rev. Physiol., vol. 78, no. 1, pp. 505–531, 2016.

M. Hargreaves and L. L. Spriet, “Exercise metabolism: fuels for the fire,” Cold Spring Harb. Perspect. Med., vol. 8, no. 8, 2018.

M. L. Parolin, A. Chesley, M. P. Matsos, L. L. Spriet, N. L. Jones, and G. J. Heigenhauser, “Regulation of skeletal muscle glycogen phosphorylase and PDH during maximal intermittent exercise,” American Journal of Physiology-Endocrinology and Metabolism, vol. 277, no. 5, pp. E890–E900, 1999.

G. A. Brooks, “The science and translation of lactate shuttle theory,” Cell Metabolism, vol. 27, no. 4, pp. 757–785, 2018.

P. B. Gastin, “Energy system interaction and relative contribution during maximal exercise,” Sports Medicine, vol. 31, no. 10, pp. 725–741, 2001.

J. A. Romijn, E. F. Coyle, L. S. Sidossis et al., “Regulation of endogenous fat and carbohydrate metabolism in relation to exercise intensity and duration,” American Journal of Physiology-Endocrinology and Metabolism, vol. 265, no. 3, pp. E380–E391, 1993.

J. A. Romijn, E. F. Coyle, L. S. Sidossis, X. J. Zhang, and R. R. Wolfe, “Relationship between fatty acid delivery and fatty acid oxidation during strenuous exercise,” Journal of Applied Physiology, vol. 79, no. 6, pp. 1939–1945, 1995.

J. O. Holloszy, “Biochemical adaptations in muscle. Effects of exercise on mitochondrial oxygen uptake and respiratory enzyme activity in skeletal muscle,” Journal of Biological Chemistry, vol. 242, no. 9, pp. 2278–2282, 1967.

B. Egan and J. R. Zierath, “Exercise metabolism and the molecular regulation of skeletal muscle adaptation,” Cell Metabolism, vol. 17, no. 2, pp. 162–184, 2013.

P. D. Gollnick and D. W. King, “Effect of exercise and training on mitochondria of rat skeletal muscle,” American Journal of Physiology-Legacy Content, vol. 216, no. 6, pp. 1502–1509, 1969.

S. A. Jubrias, P. C. Esselman, L. B. Price, M. E. Cress, and K. E. Conley, “Large energetic adaptations of elderly muscle to resistance and endurance training,” Journal of Applied Physiology, vol. 90, no. 5, pp. 1663–1670, 2001.

H. Hoppeler and S. L. Lindstedt, “Malleability of skeletal muscle in overcoming limitations: structural elements,” Journal of Experimental Biology, vol. 115, pp. 355–364, 1985.

D. A. Hood, I. Irrcher, V. Ljubicic, and A.-M. Joseph, “Coordination of metabolic plasticity in skeletal muscle,” Journal of Experimental Biology, vol. 209, no. 12, pp. 2265–2275, 2006.

K. E. Conley, “Mitochondria to motion: optimizing oxidative phosphorylation to improve exercise performance,” The Journal of Experimental Biology, vol. 219, no. 2, pp. 243–249, 2016.

D. A. Hood, “Invited Review: contractile activity-induced mitochondrial biogenesis in skeletal muscle,” Journal of Applied Physiology, vol. 90, no. 3, pp. 1137–1157, 2001.

M. Takahashi and D. A. Hood, “Protein import into subsarcolemmal and intermyofibrillar skeletal muscle mitochondria,” Journal of Biological Chemistry, vol. 271, no. 44, pp. 27285–27291, 1996.

H. Hoppeler, “Exercise-induced ultrastructural changes in skeletal muscle,” International Journal of Sports Medicine, vol. 07, no. 04, pp. 187–204, 1986.

V. P. Skulachev, “Mitochondrial filaments and clusters as intracellular power-transmitting cables,” Trends in Biochemical Sciences, vol. 26, no. 1, pp. 23–29, 2001.

A.-K. Meinild Lundby, R. A. Jacobs, S. Gehrig et al., “Exercise training increases skeletal muscle mitochondrial volume density by enlargement of existing mitochondria and not de novo biogenesis,” Acta Physiologica, vol. 222, no. 1, 2018.

C. L. Axelrod, C. E. Fealy, A. Mulya, and J. P. Kirwan, “Exercise training remodels human skeletal muscle mitochondrial fission and fusion machinery towards a pro-elongation phenotype,” Acta Physiologica, vol. 225, no. 4, article e13216, 2018.

C. E. Fealy, A. Mulya, N. Lai, and J. P. Kirwan, “Exercise training decreases activation of the mitochondrial fission protein dynamin-related protein-1 in insulin-resistant human skeletal muscle,” Journal of Applied Physiology, vol. 117, no. 3, pp. 239–245, 2014.

R. Boushel, C. Lundby, K. Qvortrup, and K. Sahlin, “Mitochondrial plasticity with exercise training and extreme environments,” Exercise and Sport Sciences Reviews, vol. 42, no. 4, pp. 169–174, 2014.

B. Glancy, L. M. Hartnell, C. A. Combs et al., “Power grid protection of the muscle mitochondrial reticulum,” Cell Reports, vol. 19, no. 3, pp. 487–496, 2017.

A. V. Palladin, “The biochemistry of muscle training,” Science, vol. 102, no. 2658, pp. 576–578, 1945.

D. E. Befroy, K. F. Petersen, S. Dufour, G. F. Mason, D. L. Rothman, and G. I. Shulman, “Increased substrate oxidation and mitochondrial uncoupling in skeletal muscle of endurance-trained individuals,” Proceedings of the National Academy of Sciences, vol. 105, no. 43, pp. 16701–16706, 2008.

D. A. Hood, G. Uguccioni, A. Vainshtein, and D. D’souza, “Mechanisms of Exercise-Induced Mitochondrial Biogenesis in Skeletal Muscle: Implications for Health and Disease,” Comprehensive Physiology, vol. 1, no. 3, pp. 1119–1134, 2011.

E. F. Coyle, W. H. Martin 3rd, D. R. Sinacore, M. J. Joyner, J. M. Hagberg, and J. O. Holloszy, “Time course of loss of adaptations after stopping prolonged intense endurance training,” Journal of Applied Physiology, vol. 57, no. 6, pp. 1857–1864, 1984.

J. C. Drake, R. J. Wilson, and Z. Yan, “Molecular mechanisms for mitochondrial adaptation to exercise training in skeletal muscle,” The FASEB Journal, vol. 30, no. 1, pp. 13–22, 2016.

D. A. Hood, L. D. Tryon, H. N. Carter, Y. Kim, and C. C. W. Chen, “Unravelling the mechanisms regulating muscle mitochondrial biogenesis,” Biochemical Journal, vol. 473, no. 15, pp. 2295–2314, 2016.

K. Baar, Z. Song, C. Semenkovich et al., “Skeletal muscle overexpression of nuclear respiratory factor 1 increases glucose transport capacity,” The FASEB Journal, vol. 17, no. 12, pp. 1666–1673, 2003.

H. Wu, S. B. Kanatous, F. A. Thurmond et al., “Regulation of mitochondrial biogenesis in skeletal muscle by CaMK,” Science, vol. 296, no. 5566, pp. 349–352, 2002.

D. Freyssenet, M. Di Carlo, and D. A. Hood, “Calcium-dependent regulation of cytochrome c gene expression in skeletal muscle cells. Identification of a protein kinase c-dependent pathway,” Journal of Biological Chemistry, vol. 274, no. 14, pp. 9305–9311, 1999.

D. G. Hardie, “AMP-activated/SNF1 protein kinases: conserved guardians of cellular energy,” Nature Reviews Molecular Cell Biology, vol. 8, no. 10, pp. 774–785, 2007.

S. Herzig and R. J. Shaw, “AMPK: Guardian of metabolism and mitochondrial homeostasis,” Nature Reviews Molecular Cell Biology, vol. 19, no. 2, pp. 121–135, 2017.

R. Bergeron, J. M. Ren, K. S. Cadman et al., “Chronic activation of AMP kinase results in NRF-1 activation and mitochondrial biogenesis,” American Journal of Physiology-Endocrinology and Metabolism, vol. 281, no. 6, pp. E1340–E1346, 2001.

W. W. Winder, B. F. Holmes, D. S. Rubink, E. B. Jensen, M. Chen, and J. O. Holloszy, “Activation of AMP-activated protein kinase increases mitochondrial enzymes in skeletal muscle,” Journal of Applied Physiology, vol. 88, no. 6, pp. 2219–2226, 2000.

N. J. Hoffman, B. L. Parker, R. Chaudhuri et al., “Global phosphoproteomic analysis of human skeletal muscle reveals a network of exercise-regulated kinases and AMPK substrates,” Cell Metabolism, vol. 22, no. 5, pp. 922–935, 2015.

Y. Zhang, G. Uguccioni, V. Ljubicic et al., “Multiple signaling pathways regulate contractile activity-mediated PGC-1α gene expression and activity in skeletal muscle cells,” Physiological Reports, vol. 2, no. 5, article e12008, 2014.

J. R. Revollo, A. A. Grimm, and S. Imai, “The NAD biosynthesis pathway mediated by nicotinamide phosphoribosyltransferase regulates Sir2 activity in mammalian cells,” Journal of Biological Chemistry, vol. 279, no. 49, pp. 50754–50763, 2004.

C. Cantó, Z. Gerhart-Hines, J. N. Feige et al., “AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity,” Nature, vol. 458, no. 7241, pp. 1056–1060, 2009.

I. Irrcher, P. J. Adhihetty, T. Sheehan, A.-M. Joseph, and D. A. Hood, “PPARgamma coactivator-1alpha expression during thyroid hormone- and contractile activity-induced mitochondrial adaptations,” American Journal of Physiology-Cell Physiology, vol. 284, no. 6, pp. C1669–C1677, 2003.

I. Irrcher, V. Ljubicic, and D. A. Hood, “Interactions between ROS and AMP kinase activity in the regulation of PGC-1alpha transcription in skeletal muscle cells,” American Journal of Physiology-Cell Physiology, vol. 296, no. 1, pp. C116–C123, 2009.

S. Jager, C. Handschin, J. St-Pierre, and B. M. Spiegelman, “AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1alpha,” Proceedings of the National Academy of Sciences, vol. 104, no. 29, pp. 12017–12022, 2007.

R. C. Scarpulla, “Nucleus-encoded regulators of mitochondrial function: integration of respiratory chain expression, nutrient sensing and metabolic stress,” Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms, vol. 1819, no. 9-10, pp. 1088–1097, 2012.

R. C. Scarpulla, R. B. Vega, and D. P. Kelly, “Transcriptional integration of mitochondrial biogenesis,” Trends in Endocrinology & Metabolism, vol. 23, no. 9, pp. 459–466, 2012.

Z. Gan, T. Fu, D. P. Kelly, and R. B. Vega, “Skeletal muscle mitochondrial remodeling in exercise and diseases,” Cell Research, vol. 28, no. 10, pp. 969–980, 2018.

C. G. R. Perry and J. A. Hawley, “Molecular basis of exercise-induced skeletal muscle mitochondrial biogenesis: historical advances, current knowledge, and future challenges,” Cold Spring Harbor Perspectives in Medicine, vol. 8, no. 9, 2018.

B. Egan, B. P. Carson, P. M. Garcia-Roves et al., “Exercise intensity-dependent regulation of peroxisome proliferator-activated receptor coactivator-1 mRNA abundance is associated with differential activation of upstream signalling kinases in human skeletal muscle,” The Journal of Physiology, vol. 588, no. 10, pp. 1779–1790, 2010.

M. Fiorenza, T. P. Gunnarsson, M. Hostrup et al., “Metabolic stress-dependent regulation of the mitochondrial biogenic molecular response to high-intensity exercise in human skeletal muscle,” The Journal of Physiology, vol. 596, no. 14, pp. 2823–2840, 2018.

C. Cantó, L. Q. Jiang, A. S. Deshmukh et al., “Interdependence of AMPK and SIRT1 for metabolic adaptation to fasting and exercise in skeletal muscle,” Cell Metabolism, vol. 11, no. 3, pp. 213–219, 2010.

H. Pilegaard, B. Saltin, and P. D. Neufer, “Exercise induces transient transcriptional activation of the PGC-1alpha gene in human skeletal muscle,” The Journal of Physiology, vol. 546, no. 3, pp. 851–858, 2003.

K. Baar, A. Wende, T. Jones et al., “Adaptations of skeletal muscle to exercise: rapid increase in the transcriptional coactivator PGC-1,” The FASEB Journal, vol. 16, no. 14, pp. 1879–1886, 2002.

S. Terada, K. Kawanaka, M. Goto, T. Shimokawa, and I. Tabata, “Effects of high-intensity intermittent swimming on PGC-1alpha protein expression in rat skeletal muscle,” Acta Physiologica Scandinavica, vol. 184, no. 1, pp. 59–65, 2005.

T. Akimoto, S. C. Pohnert, P. Li et al., “Exercise stimulates Pgc-1alpha transcription in skeletal muscle through activation of the p38 MAPK pathway,” Journal of Biological Chemistry, vol. 280, no. 20, pp. 19587–19593, 2005.

T. Akimoto, P. Li, and Z. Yan, “Functional interaction of regulatory factors with the Pgc-1alpha promoter in response to exercise by in vivo imaging,” American Journal of Physiology-Cell Physiology, vol. 295, no. 1, pp. C288–C292, 2008.

Z. Yan, P. Li, and T. Akimoto, “Transcriptional control of the Pgc-1alpha gene in skeletal muscle in vivo,” Exercise and Sport Sciences Reviews, vol. 35, no. 3, pp. 97–101, 2007.

A. Safdar, J. P. Little, A. J. Stokl, B. P. Hettinga, M. Akhtar, and M. A. Tarnopolsky, “Exercise increases mitochondrial PGC-1alpha content and promotes nuclear-mitochondrial cross-talk to coordinate mitochondrial biogenesis,” Journal of Biological Chemistry, vol. 286, no. 12, pp. 10605–10617, 2011.

C. Granata, R. S. F. Oliveira, J. P. Little, K. Renner, and D. J. Bishop, “Sprint-interval but not continuous exercise increases PGC-1α protein content and p53 phosphorylation in nuclear fractions of human skeletal muscle,” Scientific Reports, vol. 7, no. 1, 2017.

C. Handschin, J. Rhee, J. Lin, P. T. Tarr, and B. M. Spiegelman, “An autoregulatory loop controls peroxisome proliferator-activated receptor gamma coactivator 1alpha expression in muscle,” Proceedings of the National Academy of Sciences, vol. 100, no. 12, pp. 7111–7116, 2003.

A. Saleem, P. J. Adhihetty, and D. A. Hood, “Role of p53 in mitochondrial biogenesis and apoptosis in skeletal muscle,” Physiological Genomics, vol. 37, no. 1, pp. 58–66, 2009.

J. D. Bartlett, G. L. Close, B. Drust, and J. P. Morton, “The emerging role of p53 in exercise metabolism,” Sports Medicine, vol. 44, no. 3, pp. 303–309, 2014.

J. D. Bartlett, J. Louhelainen, Z. Iqbal et al., “Reduced carbohydrate availability enhances exercise-induced p53 signaling in human skeletal muscle: implications for mitochondrial biogenesis,” American Journal of Physiology-Regulatory, Integrative and Comparative Physiology, vol. 304, no. 6, pp. R450–R458, 2013.

A. Philp, A. Chen, D. Lan et al., “Sirtuin 1 (SIRT1) Deacetylase Activity Is Not Required for Mitochondrial Biogenesis or Peroxisome Proliferator-activated Receptor-γ Coactivator-1α (PGC-1α) Deacetylation following Endurance Exercise,” Journal of Biological Chemistry, vol. 286, no. 35, pp. 30561–30570, 2011.

A. Saleem, H. N. Carter, and D. A. Hood, “p53 is necessary for the adaptive changes in cellular milieu subsequent to an acute bout of endurance exercise,” American Journal of Physiology-Cell Physiology, vol. 306, no. 3, pp. C241–C249, 2014.

S. Matoba, J. G. Kang, W. D. Patino et al., “p53 regulates mitochondrial respiration,” Science, vol. 312, no. 5780, pp. 1650–1653, 2006.

A. Saleem and D. A. Hood, “Acute exercise induces tumour suppressor protein p53 translocation to the mitochondria and promotes a p53-Tfam-mitochondrial DNA complex in skeletal muscle,” The Journal of Physiology, vol. 591, no. 14, pp. 3625–3636, 2013.

C. Granata, N. A. Jamnick, and D. J. Bishop, “Training-induced changes in mitochondrial content and respiratory function in human skeletal muscle,” Sports Medicine, vol. 48, no. 8, pp. 1809–1828, 2018.

D. J. Bishop, C. Granata, and N. Eynon, “Can we optimise the exercise training prescription to maximise improvements in mitochondria function and content?” Biochimica et Biophysica Acta (BBA) - General Subjects, vol. 1840, no. 4, pp. 1266–1275, 2014.

C. Granata, R. S. F. Oliveira, J. P. Little, K. Renner, and D. J. Bishop, “Training intensity modulates changes in PGC-1α and p53 protein content and mitochondrial respiration, but not markers of mitochondrial content in human skeletal muscle,” The FASEB Journal, vol. 30, no. 2, pp. 959–970, 2016.

M. Buchheit and P. B. Laursen, “High-Intensity Interval Training, Solutions to the Programming Puzzle,” Sports Medicine, vol. 43, no. 10, pp. 927–954, 2013.

S. Seiler, K. Joranson, B. V. Olesen, and K. J. Hetlelid, “Adaptations to aerobic interval training: interactive effects of exercise intensity and total work duration,” Scandinavian Journal of Medicine & Science in Sports, vol. 23, no. 1, pp. 74–83, 2013.

F. M. Iaia and J. Bangsbo, “Speed endurance training is a powerful stimulus for physiological adaptations and performance improvements of athletes,” Scandinavian Journal of Medicine & Science in Sports, vol. 20, Suppl 2, pp. 11–23, 2010.

C. G. R. Perry, J. Lally, G. P. Holloway, G. J. F. Heigenhauser, A. Bonen, and L. L. Spriet, “Repeated transient mRNA bursts precede increases in transcriptional and mitochondrial proteins during training in human skeletal muscle,” The Journal of Physiology, vol. 588, no. 23, pp. 4795–4810, 2010.

J. P. Little, A. Safdar, G. P. Wilkin, M. A. Tarnopolsky, and M. J. Gibala, “A practical model of low-volume high-intensity interval training induces mitochondrial biogenesis in human skeletal muscle: potential mechanisms,” The Journal of Physiology, vol. 588, no. 6, pp. 1011–1022, 2010.

M. J. Gibala, J. P. Little, M. van Essen et al., “Short-term sprint interval versus traditional endurance training: similar initial adaptations in human skeletal muscle and exercise performance,” The Journal of Physiology, vol. 575, no. 3, pp. 901–911, 2006.

K. A. Burgomaster, K. R. Howarth, S. M. Phillips et al., “Similar metabolic adaptations during exercise after low volume sprint interval and traditional endurance training in humans,” The Journal of Physiology, vol. 586, no. 1, pp. 151–160, 2008.

M. J. MacInnis and M. J. Gibala, “Physiological adaptations to interval training and the role of exercise intensity,” The Journal of Physiology, vol. 595, no. 9, pp. 2915–2930, 2017.

N. Place, N. Ivarsson, T. Venckunas et al., “Ryanodine receptor fragmentation and sarcoplasmic reticulum Ca2+ leak after one session of high-intensity interval exercise,” Proceedings of the National Academy of Sciences, vol. 112, no. 50, pp. 15492–15497, 2015.

D. Morales-Alamo, J. G. Ponce-González, A. Guadalupe-Grau et al., “Increased oxidative stress and anaerobic energy release, but blunted Thr172-AMPKα phosphorylation, in response to sprint exercise in severe acute hypoxia in humans,” Journal of Applied Physiology, vol. 113, no. 6, pp. 917–928, 2012.

M. J. MacInnis, E. Zacharewicz, B. J. Martin et al., “Superior mitochondrial adaptations in human skeletal muscle after interval compared to continuous single-leg cycling matched for total work,” The Journal of Physiology, vol. 595, no. 9, pp. 2955–2968, 2017.

R. C. Laker, J. C. Drake, R. J. Wilson et al., “Ampk phosphorylation of Ulk1 is required for targeting of mitochondria to lysosomes in exercise-induced mitophagy,” Nature Communications, vol. 8, no. 1, p. 548, 2017.

M. Lavorato, E. Loro, V. Debattisti, T. S. Khurana, and C. Franzini-Armstrong, “Elongated mitochondrial constrictions and fission in muscle fatigue,” Journal of Cell Science, vol. 131, no. 23, p. jcs221028, 2018.

E. Q. Toyama, S. Herzig, J. Courchet et al., “Metabolism. AMP-activated protein kinase mediates mitochondrial fission in response to energy stress,” Science, vol. 351, no. 6270, pp. 275–281, 2016.

V. Romanello, E. Guadagnin, L. Gomes et al., “Mitochondrial fission and remodelling contributes to muscle atrophy,” The EMBO Journal, vol. 29, no. 10, pp. 1774–1785, 2010.

T. M. Moore, Z. Zhou, W. Cohn et al., “The impact of exercise on mitochondrial dynamics and the role of Drp1 in exercise performance and training adaptations in skeletal muscle,” Molecular Metabolism, vol. 21, pp. 51–67, 2019.

P. Mishra and D. C. Chan, “Metabolic regulation of mitochondrial dynamics,” The Journal of Cell Biology, vol. 212, no. 4, pp. 379–387, 2016.

A. Franco, R. N. Kitsis, J. A. Fleischer et al., “Correcting mitochondrial fusion by manipulating mitofusin conformations,” Nature, vol. 540, no. 7631, pp. 74–79, 2016.

M. Liesa, B. Borda-d'Água, G. Medina-Gómez et al., “Mitochondrial fusion is increased by the nuclear coactivator PGC-1beta,” PLoS One, vol. 3, no. 10, article e3613, 2008.

F. X. Soriano, M. Liesa, D. Bach, D. C. Chan, M. Palacin, and A. Zorzano, “Evidence for a Mitochondrial Regulatory Pathway Defined by Peroxisome Proliferator-Activated Receptor- Coactivator-1 , Estrogen-Related Receptor- , and Mitofusin 2,” Diabetes, vol. 55, no. 6, pp. 1783–1791, 2006.

R. Cartoni, B. Léger, M. B. Hock et al., “Mitofusins 1/2 and ERRalpha expression are increased in human skeletal muscle after physical exercise,” The Journal of Physiology, vol. 567, no. 1, pp. 349–358, 2005.

M. Picard, B. J. Gentil, M. J. McManus et al., “Acute exercise remodels mitochondrial membrane interactions in mouse skeletal muscle,” Journal of Applied Physiology, vol. 115, no. 10, pp. 1562–1571, 2013.

J. F. Halling, S. Ringholm, J. Olesen, C. Prats, and H. Pilegaard, “Exercise training protects against aging-induced mitochondrial fragmentation in mouse skeletal muscle in a PGC-1α dependent manner,” Experimental Gerontology, vol. 96, pp. 1–6, 2017.

C. Tezze, V. Romanello, M. A. Desbats et al., “Age-associated loss of OPA1 in muscle impacts muscle mass, metabolic homeostasis, systemic inflammation, and epithelial senescence,” Cell Metabolism, vol. 25, no. 6, pp. 1374–1389.e6, 2017.

M. Fiorenza, T. P. Gunnarsson, T. S. Ehlers, and J. Bangsbo, “High-intensity exercise training ameliorates aberrant expression of markers of mitochondrial turnover but not oxidative damage in skeletal muscle of men with essential hypertension,” Acta Physiologica, vol. 225, no. 3, article e13208, 2018.

J. C. Drake and Z. Yan, “Mitophagy in maintaining skeletal muscle mitochondrial proteostasis and metabolic health with ageing,” The Journal of Physiology, vol. 595, no. 20, pp. 6391–6399, 2017.

F. J. Larsen, T. A. Schiffer, N. Ørtenblad et al., “High-intensity sprint training inhibits mitochondrial respiration through aconitase inactivation,” The FASEB Journal, vol. 30, no. 1, pp. 417–427, 2016.

C. Zinner, D. Morales-Alamo, N. Ørtenblad et al., “The physiological mechanisms of performance enhancement with sprint interval training differ between the upper and lower extremities in humans,” Frontiers in Physiology, vol. 7, no. 426, 2016.

J. Nielsen, K. D. Gejl, M. Hey-Mogensen et al., “Plasticity in mitochondrial cristae density allows metabolic capacity modulation in human skeletal muscle,” The Journal of Physiology, vol. 595, no. 9, pp. 2839–2847, 2017.

R. W. Gilkerson, J. M. L. Selker, and R. A. Capaldi, “The cristal membrane of mitochondria is the principal site of oxidative phosphorylation,” FEBS Letters, vol. 546, no. 2-3, pp. 355–358, 2003.

J. R. Huertas, S. Al Fazazi, A. Hidalgo-Gutierrez, L. C. López, and R. A. Casuso, “Antioxidant effect of exercise: exploring the role of the mitochondrial complex I superassembly,” Redox Biology, vol. 13, pp. 477–481, 2017.

C. Greggio, P. Jha, S. S. Kulkarni et al., “Enhanced respiratory chain supercomplex formation in response to exercise in human skeletal muscle,” Cell Metabolism, vol. 25, no. 2, pp. 301–311, 2017.

R. A. Casuso, J. Plaza-Díaz, F. J. Ruiz-Ojeda et al., “High-intensity high-volume swimming induces more robust signaling through PGC-1α and AMPK activation than sprint interval swimming in m. triceps brachii,” PLoS One, vol. 12, no. 10, article e0185494, 2017.

R. A. Casuso, J. Aragon-Vela, J. R. Huertas, A. Ruiz-Ariza, and E. J. Martinez-Lopez, “Comparison of the inflammatory and stress response between sprint interval swimming and running,” Scandinavian Journal of Medicine & Science in Sports, vol. 28, no. 4, pp. 1371–1378, 2018.

L. A. Gomez and T. M. Hagen, “Age-related decline in mitochondrial bioenergetics: does supercomplex destabilization determine lower oxidative capacity and higher superoxide production?” Seminars in Cell & Developmental Biology, vol. 23, no. 7, pp. 758–767, 2012.

M. G. Rosca, E. J. Vazquez, J. Kerner et al., “Cardiac mitochondria in heart failure: decrease in respirasomes and oxidative phosphorylation,” Cardiovascular Research, vol. 80, no. 1, pp. 30–39, 2008.

G. Antoun, F. McMurray, A. B. Thrush et al., “Impaired mitochondrial oxidative phosphorylation and supercomplex assembly in rectus abdominis muscle of diabetic obese individuals,” Diabetologia, vol. 58, no. 12, pp. 2861–2866, 2015.

E. Schäfer, H. Seelert, N. H. Reifschneider, F. Krause, N. A. Dencher, and J. Vonck, “Architecture of active mammalian respiratory chain supercomplexes,” Journal of Biological Chemistry, vol. 281, no. 22, pp. 15370–15375, 2006.

K. Kuter, M. Kratochwil, K. Berghauzen-Maciejewska et al., “Adaptation within mitochondrial oxidative phosphorylation supercomplexes and membrane viscosity during degeneration of dopaminergic neurons in an animal model of early Parkinson’s disease,” Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, vol. 1862, no. 4, pp. 741–753, 2016.

C. Wernicke, J. Hellmann, B. Zięba et al., “9-Methyl-β-carboline has restorative effects in an animal model of Parkinson’s disease,” Pharmacological Reports, vol. 62, no. 1, pp. 35–53, 2010.

I. Lopez-Fabuel, M. Resch-Beusher, M. Carabias-Carrasco, A. Almeida, and J. P. Bolaños, “Mitochondrial complex I activity is conditioned by supercomplex I–III2–IV assembly in brain cells: relevance for Parkinson’s disease,” Neurochemical Research, vol. 42, no. 6, pp. 1676–1682, 2017.

V. A. Narkar, M. Downes, R. T. Yu et al., “AMPK and PPARdelta agonists are exercise mimetics,” Cell, vol. 134, no. 3, pp. 405–415, 2008.

N. J. Kang, S. H. Shin, H. J. Lee, and K. W. Lee, “Polyphenols as small molecular inhibitors of signaling cascades in carcinogenesis,” Pharmacology & Therapeutics, vol. 130, no. 3, pp. 310–324, 2011.

C. Manach, A. Scalbert, C. Morand, C. Remesy, and L. Jimenez, “Polyphenols: food sources and bioavailability,” The American Journal of Clinical Nutrition, vol. 79, no. 5, pp. 727–747, 2004.

M. Lagouge, C. Argmann, Z. Gerhart-Hines et al., “Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha,” Cell, vol. 127, no. 6, pp. 1109–1122, 2006.

N. L. Price, A. P. Gomes, A. J. Y. Ling et al., “SIRT1 is required for AMPK activation and the beneficial effects of resveratrol on mitochondrial function,” Cell Metabolism, vol. 15, no. 5, pp. 675–690, 2012.

K. J. Menzies, K. Singh, A. Saleem, and D. A. Hood, “Sirtuin 1-mediated effects of exercise and resveratrol on mitochondrial biogenesis,” Journal of Biological Chemistry, vol. 288, no. 10, pp. 6968–6979, 2013.

R. A. Casuso, E. J. Martínez-López, N. B. Nordsborg et al., “Oral quercetin supplementation hampers skeletal muscle adaptations in response to exercise training,” Scandinavian Journal of Medicine & Science in Sports, vol. 24, no. 6, pp. 920–927, 2014.

J. M. Davis, E. A. Murphy, M. D. Carmichael, and B. Davis, “Quercetin increases brain and muscle mitochondrial biogenesis and exercise tolerance,” American Journal of Physiology-Regulatory, Integrative and Comparative Physiology, vol. 296, no. 4, pp. R1071–R1077, 2009.

S. Timmers, E. Konings, L. Bilet et al., “Calorie restriction-like effects of 30 days of resveratrol supplementation on energy metabolism and metabolic profile in obese humans,” Cell Metabolism, vol. 14, no. 5, pp. 612–622, 2011.

J. Yoshino, C. Conte, L. Fontana et al., “Resveratrol supplementation does not improve metabolic function in nonobese women with normal glucose tolerance,” Cell Metabolism, vol. 16, no. 5, pp. 658–664, 2012.

L. Gliemann, J. F. Schmidt, J. Olesen et al., “Resveratrol blunts the positive effects of exercise training on cardiovascular health in aged men,” The Journal of Physiology, vol. 591, no. 20, pp. 5047–5059, 2013.

T. D. Scribbans, J. K. Ma, B. A. Edgett et al., “Resveratrol supplementation does not augment performance adaptations or fibre-type-specific responses to high-intensity interval training in humans,” Applied Physiology, Nutrition, and Metabolism, vol. 39, no. 11, pp. 1305–1313, 2014.

D. Nieman, A. Williams, R. Shanely et al., “Quercetin’s influence on exercise performance and muscle mitochondrial biogenesis,” Medicine & Science in Sports & Exercise, vol. 42, no. 2, pp. 338–345, 2010.

H. S. H. MacRae and K. M. Mefferd, “Dietary antioxidant supplementation combined with quercetin improves cycling time trial performance,” International Journal of Sport Nutrition and Exercise Metabolism, vol. 16, no. 4, pp. 405–419, 2006.

J. M. Davis, C. J. Carlstedt, S. Chen, M. D. Carmichael, and E. A. Murphy, “The dietary flavonoid quercetin increases VO(2max) and endurance capacity,” International Journal of Sport Nutrition and Exercise Metabolism, vol. 20, no. 1, pp. 56–62, 2010.

D. M. Pelletier, G. Lacerte, and E. D. B. Goulet, “Effects of quercetin supplementation on endurance performance and maximal oxygen consumption: a meta-analysis,” International Journal of Sport Nutrition and Exercise Metabolism, vol. 23, no. 1, pp. 73–82, 2013.

K. J. Cureton, P. D. Tomporowski, A. Singhal et al., “Dietary quercetin supplementation is not ergogenic in untrained men,” Journal of Applied Physiology, vol. 107, no. 4, pp. 1095–1104, 2009.

S. V. Brooks, A. Vasilaki, L. M. Larkin, A. McArdle, and M. J. Jackson, “Repeated bouts of aerobic exercise lead to reductions in skeletal muscle free radical generation and nuclear factor kappaB activation,” The Journal of Physiology, vol. 586, no. 16, pp. 3979–3990, 2008.

H. Sies, “Hydrogen peroxide as a central redox signaling molecule in physiological oxidative stress: oxidative eustress,” Redox Biology, vol. 11, pp. 613–619, 2017.

T. L. Merry and M. Ristow, “Mitohormesis in exercise training,” Free Radical Biology and Medicine, vol. 98, pp. 123–130, 2016.

M. J. Jackson, “Redox regulation of muscle adaptations to contractile activity and aging,” Journal of Applied Physiology, vol. 119, no. 3, pp. 163–171, 2015.

M.-C. Gomez-Cabrera, E. Domenech, M. Romagnoli et al., “Oral administration of vitamin C decreases muscle mitochondrial biogenesis and hampers training-induced adaptations in endurance performance,” The American Journal of Clinical Nutrition, vol. 87, no. 1, pp. 142–149, 2008.

M. Ristow, K. Zarse, A. Oberbach et al., “Antioxidants prevent health-promoting effects of physical exercise in humans,” Proceedings of the National Academy of Sciences, vol. 106, no. 21, pp. 8665–8670, 2009.

A. M. Jones, C. Thompson, L. J. Wylie, and A. Vanhatalo, “Dietary nitrate and physical performance,” Annual Review of Nutrition, vol. 38, no. 1, pp. 303–328, 2018.

F. J. Larsen, T. A. Schiffer, S. Borniquel et al., “Dietary inorganic nitrate improves mitochondrial efficiency in humans,” Cell Metabolism, vol. 13, no. 2, pp. 149–159, 2011.

S. J. Bailey, P. Winyard, A. Vanhatalo et al., “Dietary nitrate supplementation reduces the O2 cost of low-intensity exercise and enhances tolerance to high-intensity exercise in humans,” Journal of Applied Physiology, vol. 107, no. 4, pp. 1144–1155, 2009.

C. Thompson, A. Vanhatalo, S. Kadach et al., “Discrete physiological effects of beetroot juice and potassium nitrate supplementation following 4-wk sprint interval training,” Journal of Applied Physiology, vol. 124, no. 6, pp. 1519–1528, 2018.

A. Franco-Obregon and J. A. Gilbert, “The microbiome-mitochondrion connection: common ancestries, common mechanisms, common goals,” mSystems, vol. 2, no. 3, 2017.

M. D. Cook, J. M. Allen, B. D. Pence et al., “Exercise and gut immune function: evidence of alterations in colon immune cell homeostasis and microbiome characteristics with exercise training,” Immunology and Cell Biology, vol. 94, no. 2, pp. 158–163, 2016.

M. Estaki, J. Pither, P. Baumeister et al., “Cardiorespiratory fitness as a predictor of intestinal microbial diversity and distinct metagenomic functions,” Microbiome, vol. 4, no. 1, p. 42, 2016.

A. Clark and N. Mach, “The crosstalk between the gut microbiota and mitochondria during exercise,” Frontiers in Physiology, vol. 8, 2017.

B. K. Pedersen, “Which type of exercise keeps you young?” Current Opinion in Clinical Nutrition and Metabolic Care, vol. 22, no. 2, pp. 167–173, 2019.

G. N. Ruegsegger and F. W. Booth, “Running from disease: molecular mechanisms associating dopamine and leptin signaling in the brain with physical inactivity, obesity, and type 2 diabetes,” Frontiers in Endocrinology, vol. 8, no. 109, 2017.

K. J. Gries, U. Raue, R. K. Perkins et al., “Cardiovascular and skeletal muscle health with lifelong exercise,” Journal of Applied Physiology, vol. 125, no. 5, pp. 1636–1645, 2018.

B. K. Pedersen, “The physiology of optimizing health with a focus on exercise as medicine,” Annual Review of Physiology, vol. 81, no. 1, pp. 607–627, 2019.

B. M. Gabriel and J. R. Zierath, “The limits of exercise physiology: from performance to health,” Cell Metabolism, vol. 25, no. 5, pp. 1000–1011, 2017.

K. Mandsager, S. Harb, P. Cremer, D. Phelan, S. E. Nissen, and W. Jaber, “Association of cardiorespiratory fitness with long-term mortality among adults undergoing exercise treadmill testing,” JAMA Network Open, vol. 1, no. 6, article e183605, 2018.

M. Savikj, B. M. Gabriel, P. S. Alm et al., “Afternoon exercise is more efficacious than morning exercise at improving blood glucose levels in individuals with type 2 diabetes: a randomised crossover trial,” Diabetologia, vol. 62, no. 2, pp. 233–237, 2019.

L. Brito, T. Peçanha, R. Fecchio et al., “Morning vs evening aerobic training effects on blood pressure in treated hypertension,” Medicine & Science in Sports & Exercise, vol. 51, no. 4, pp. 653–662, 2018.

G. López-Lluch, C. Santos-Ocaña, J. A. Sánchez-Alcázar et al., “Mitochondrial responsibility in ageing process: innocent, suspect or guilty,” Biogerontology, vol. 16, no. 5, pp. 599–620, 2015.

J.-a. Kim, Y. Wei, and J. R. Sowers, “Role of mitochondrial dysfunction in insulin resistance,” Circulation Research, vol. 102, no. 4, pp. 401–414, 2008.

P. A. Andreux, R. H. Houtkooper, and J. Auwerx, “Pharmacological approaches to restore mitochondrial function,” Nature Reviews Drug Discovery, vol. 12, no. 6, pp. 465–483, 2013.

J. L. Brown, M. E. Rosa-Caldwell, D. E. Lee et al., “Mitochondrial degeneration precedes the development of muscle atrophy in progression of cancer cachexia in tumour-bearing mice,” Journal of Cachexia, Sarcopenia and Muscle, vol. 8, no. 6, pp. 926–938, 2017.

M. Frenzel, H. Rommelspacher, M. D. Sugawa, and N. A. Dencher, “Ageing alters the supramolecular architecture of OxPhos complexes in rat brain cortex,” Experimental Gerontology, vol. 45, no. 7-8, pp. 563–572, 2010.

R. Acin-Perez, A. V. Lechuga-Vieco, M. del Mar Muñoz et al., “Ablation of the stress protease OMA1 protects against heart failure in mice,” Science Translational Medicine, vol. 10, no. 434, article eaan4935, 2018.